Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

929
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

886
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

340
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

971
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

319
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Characteristics Associated with Poor Long-Term Outcomes in Patients with Fontan Palliation: A Case-Control Study.

Pediatric cardiology·2026
Same author

Explantation of durable ventricular assist device for myocardial functional recovery in children: A report from the ACTION registry.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

The Ninth Annual STS-Pedimacs Report: Pediatric VAD Outcomes and the Expanding Role of Biventricular Support.

The Annals of thoracic surgery·2026
Same author

Prospective Multicenter Evaluation of a Novel Active Driving System for Pediatric Ventricular Assist Device Support.

Journal of the American College of Cardiology·2026
Same author

Early donor-specific antibodies in pediatric patients with Fontan circulation after heart transplant.

Transplant immunology·2026
Same author

Multicenter Registry Analysis of Bivalirudin for Primary Anticoagulation in Pediatric HeartMate 3 Recipients: ACTION Analysis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same journal

Socioeconomic Barriers for Newly Transferred Young Adults With Congenital Heart Disease.

CJC pediatric and congenital heart disease·2026
Same journal

Use of and Experience With Wearable Biosensors in Congenital Heart Disease: A Survey Study.

CJC pediatric and congenital heart disease·2026
Same journal

Long-term Outcomes in Anomalous Left Coronary Artery From the Pulmonary Artery Syndrome: A Multicenter Half-Century Experience.

CJC pediatric and congenital heart disease·2026
Same journal

Mapping the Biopsychosocial and Lifestyle Portrait of Adults With Congenital Heart Disease: A Comparative Study Across Sex and Age.

CJC pediatric and congenital heart disease·2026
Same journal

The Canadian Fontan Connection (CANFON): Protocol for a National Lifespan Cohort of People Living With a Fontan Circulation.

CJC pediatric and congenital heart disease·2026
Same journal

Understanding the Biopsychosocial Landscape of Adults With Congenital Heart Disease.

CJC pediatric and congenital heart disease·2026
查看所有相关文章

相关实验视频

Updated: Feb 4, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

使用可穿戴数字技术捕获心力衰竭儿童的生理数据:试点项目的教训

David M Peng1, Jonathan B Edelson2, Harishwara R Gureddygari3

  • 1CS Mott Children's Hospital, Department of Pediatrics (Cardiology), University of Michigan, Ann Arbor, Michigan, USA.

CJC pediatric and congenital heart disease
|February 2, 2026
PubMed
概括
此摘要是机器生成的。

这项研究表明,使用Apple Watch收集儿科心力衰竭患者的心率和活动数据是可行的. 这些发现支持进一步研究用于管理儿科心脏病的可穿戴技术.

更多相关视频

A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
10:45

A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings

Published on: January 22, 2018

8.1K
High-resolution, High-speed, Three-dimensional Video Imaging with Digital Fringe Projection Techniques
11:34

High-resolution, High-speed, Three-dimensional Video Imaging with Digital Fringe Projection Techniques

Published on: December 3, 2013

16.1K

相关实验视频

Last Updated: Feb 4, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
10:45

A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings

Published on: January 22, 2018

8.1K
High-resolution, High-speed, Three-dimensional Video Imaging with Digital Fringe Projection Techniques
11:34

High-resolution, High-speed, Three-dimensional Video Imaging with Digital Fringe Projection Techniques

Published on: December 3, 2013

16.1K

科学领域:

  • 生物医学工程 生物医学工程
  • 儿童心脏病学 儿童心脏病学
  • 数字健康数字健康

背景情况:

  • 儿童心力衰竭对监测提出了独特的挑战.
  • 可穿戴技术为远程患者监控提供了潜力.

研究的目的:

  • 评估使用Apple Watch和定制应用程序收集儿科心力衰竭患者的生理和活动数据的可行性.
  • 描述与临床状态相关的收集数据.

主要方法:

  • 试点研究涉及五名心力衰竭的儿科患者 (12-17岁).
  • 使用Apple Watch和专门设计的应用程序收集数据.
  • 心率和活动数据与临床状态的整合.

主要成果:

  • 成功收集和描述了儿科患者的生理 (心率) 和活动数据.
  • 证明了数据收集方法的可行性.
  • 呈现的数据与临床状态和轨迹一起.

结论:

  • 使用可穿戴技术可用于监测儿科心力衰竭患者.
  • 收集的数据可以为未来的研究提供假设生成信息.
  • 对儿童心脏病的可穿戴技术进行进一步的研究是有必要的.